Skip to main content
Mediterranean Journal of Rheumatology logoLink to Mediterranean Journal of Rheumatology
. 2025 Mar 31;36(1):12–27. doi: 10.31138/mjr.041124.pht

Physical Modalities for the Treatment of Pain in Patients with Fibromyalgia

Ilke Coskun Benlidayi 1,✉
PMCID: PMC12183450  PMID: 40557176

Abstract

Generalised pain is the major symptom in patients with fibromyalgia. The management of pain includes both pharmacological and non-pharmacological options. Exercise, meditative movement therapies and mindfulness-based stress reduction are examples of non-pharmacological treatments. Over the last decades, there is growing evidence regarding the role of physical modalities in the management of fibromyalgia-related pain. Physical modalities demonstrate their effects by using several energy types such as electrical, thermal, acoustic, or radiant energy. They may act through the alteration of blood flow, cellular activity, and nerve excitability. By reviewing the recent literature, the current article aimed to provide a comprehensive insight to the potential effects of physical modalities in the treatment of fibromyalgia-related pain. Evidence regarding the potential therapeutic role of transcutaneous electrical nerve stimulation, interferential current, therapeutic ultrasound, non-invasive brain stimulation techniques (e.g. transcranial direct current stimulation, transcranial magnetic stimulation), photobiomodulation therapy [e.g. Light Amplification by Stimulated Emission of Radiation (LASER)], the use of therapeutic cold (e.g. whole-body cryotherapy) was discussed.

Keywords: fibromyalgia, pain, physical therapy modalities, physical medicine and rehabilitation

INTRODUCTION

Fibromyalgia is a rheumatic disease with multiple features including-but not limited to-generalised pain, fatigue, sleep disturbances and mood disorders.1 Widespread pain, which is the hallmark of fibromyalgia, interferes with the patient’s quality of life and general well-being. Thus, proper management of pain is essential in the treatment of fibromyalgia. The latest treatment recommendations by the European League Against Rheumatism (EULAR) includes both pharmacological and non-pharmacological approaches for the management of fibromyalgia. Moreover, EULAR endorses a graduated treatment plan focusing on non-pharmacological strategies at the beginning. Exercise is the cornerstone of non-pharmacological treatment. There are other non-pharmacological management options such as meditative movement therapies, mindfulness-based stress reduction and acupuncture.2 Physical modalities refer to a group of treatment options in which the therapeutic effect of physical forces such as heat/cold, light, sound, or electricity is used. They serve as potential and adjunctive treatment regimens in the management of pain.3 The present article aimed to provide an insight regarding the role of physical modalities in the treatment of fibromyalgia.

SEARCH STRATEGY

The current narrative review applied a search strategy recommended for narrative reviews.4 PubMed/MED-LINE and Scopus were searched for relevant articles by using the keywords “fibromyalgia”, “physical modality”, “physical modalities”, “transcutaneous electrical nerve stimulation”, “interferential current”, “cold pack”, “hot pack”, “cryotherapy”, “therapeutic ultrasound”, “diathermy”, “LASER”, “photobiomodulation”, “transcranial magnetic stimulation”, “transcranial direct current stimulation”. Randomised controlled trials, observational studies, and case-control studies published in the past 10 years till October 2022 were evaluated for eligibility. Exclusion criteria were i) articles that were not written in English language, ii) those fall outside the topic of the current review, iii) editorials, letters, conference papers, iv) study protocols, v) pilot studies, vi) studies on animals, and vii) unpublished data (Figure 1). The included articles’ reference lists were also evaluated for further relevant papers.

Figure 1.

Figure 1.

Flowchart of the search algorithm.

WHAT ARE THE TYPES OF PHYSICAL MODALITIES?

Physical modalities are a variety of therapeutic instruments, machines, and tools particularly used for the management of painful conditions/diseases of the musculoskeletal system. Their mechanism of action is primarily based on the transmission of energy to or through the patient.3 Electrotherapeutic modalities use electricity while physical agents involve thermal, acoustic, or radiant energy.5 Transcutaneous electrical nerve stimulation (TENS) and interferential current are examples of electrotherapeutic modalities. On the other hand, hot packs (superficial heat) and therapeutic ultrasound are examples of physical modalities using thermal and acoustic energy, respectively (Figure 2).

Figure 2.

Figure 2.

Physical modalities. Illustrated by the author. WBC: whole-body cryotherapy; TENS: transcutaneous electrical nerve stimulation; tDCS: transcranial direct current stimulation; rTMS: repetitive transcranial magnetic stimulation; US: ultrasound, IFC: interferential current; LLLT: low-level LASER therapy; LED: low-intensity light-emitting diode.

How do physical modalities improve pain?

There are several mechanisms underlying the pain-relief effect of physical modalities:

Electrical physical modalities serve through the activation of pain gate mechanisms, transferring mechanical forces in order to change the physical properties of tissues, stimulation of cellular activity involving in healing and repair, alteration of blood flow and reduction of inflammation.6 Thermal physical agents induce vasodilatation, increase blood flow and metabolism, enhance extensibility and activate the transient receptor potential (TRP) channel, thereby reduce pain.7

Photobiomodulation therapy (PBMT) can induce cell proliferation and prevent cell death, thus can enhance tissue regeneration and the healing process. It also has anti-inflammatory and analgesic effects. The PBMT light is directly absorbed by the receptors of nerve cells. Following the absorption, the PBMT light increases the porosity of the nerve cell membrane and leads to the increased reabsorption of sodium ions, while the expulsion of potassium ions. The rebalance of the sodium-potassium pump within the nerve cell membrane prevents the nerve from reaching threshold. The mechanism underlying the analgesic effects of PBMT resembles the postsynaptic inhibition achieved by opioids.8

Therapeutic effectiveness of ultrasound is based on thermal and non-thermal effects. By its thermal effects, therapeutic ultrasound can cause changes in nerve conduction velocity, enzymatic activity, and contractile activity of skeletal muscles. It can also increase collagen tissue extensibility, local blood flow and pain threshold, and can reduce muscle spasm. On the other hand, non-thermal effects can lead to alteration in cell membrane activity, vascular wall permeability, and facilitation of soft tissue healing.9

What is already known regarding the potential therapeutic role of physical modalities in fibromyalgia?

It is a well-known fact that exercising is the cornerstone of non-pharmacological management of fibromyalgia. Aerobic or mixed exercise regimens have been shown to improve pain intensity and health related quality of life in patients with fibromyalgia.10,11 In this regard, EULAR provided strong recommendations for exercising in the management of fibromyalgia.2 Yet, given the complex nature of fibromyalgia, other non-pharmacological options such as physical modalities may have potential value as adjuvant therapy options in management.

The effectiveness of several physical modalities in the management of fibromyalgia-related pain has been studied so far (Table 1 and Table 2). Transcutaneous electrical nerve stimulation is one of the most studied modalities among patients with fibromyalgia.12–27 A Cochrane review by Johnson et al. evaluated 7 randomised controlled trials and 1 quasi-randomised trial of TENS treatment for pain related to fibromyalgia in 315 adult patients.28 The authors of the Cochrane review concluded that there was insufficient high-quality evidence to support or refute the use of TENS for patients with fibromyalgia.28 After then, several other studies assessed potential TENS-induced pain reduction in fibromyalgia. For instance, the Fibromyalgia Activity Study with TENS (FAST) study by Dailey et al., examined the effects of modulated frequency (2–125 Hz) TENS with highest tolerable intensity applied to the lumbar and cervicothoracic regions 2 hours/day for 4 weeks.15 Patients in the active TENS group exhibited greater improvement in movement-evoked pain, movement-evoked fatigue and global impression of change compared to those in placebo TENS or no TENS groups.15 Secondary analysis of data from FAST study revealed that the response to an initial 30-minute TENS treatment was a predictor of the response to longer-term TENS. Moreover, the results showed that TENS was safe and effective. Number needed to treat for pain and fatigue were 3.3 and 5.3, respectively. Number needed to harm for individual adverse events ranged between 20 and 100 for active-TENS when compared to either placebo-TENS or no-TENS treatments.16 Jamison et al., in their randomised controlled study, evaluated the effects of TENS in fibromyalgia.14 The results revealed modest treatment effects on pain, functional impairment and disease impact. Moreover, patients with higher pain sensitivity exhibited greater patient global impression of change by TENS than those with lower pain sensitivity. Wearable TENS appeared to be a safe treatment option for patients with fibromyalgia.14 It is of note to state that studies so far vary in the design (frequency, intensity, duration, treatment groups) and evaluation (outcome measures) of TENS treatments. As a cheap, easily-applied and relatively safe modality, TENS stands as a potential adjunctive treatment option for patients with fibromyalgia. Yet, adequately powered future studies with complete reporting of study designs and treatment interventions would be of value to improve our understanding in terms of the effects of TENS on fibromyalgia-related pain. The results of the studies involving the effects of TENS for fibromyalgia-related pain are provided in Table 1.

Table 1.

Results of studies involving effects of transcutaneous electrical nerve stimulation, therapeutic ultrasound, interferential current, and photobiomodulation therapy for fibromyalgia-related pain.

Study Intervention(s) Outcome measures Results
Dailey et al.12
  • -Active TENS

  • -Placebo TENS

  • -No TENS

Movement-evoked pain, NRS-resting pain, SF-36, fatigue, FIQR, BPI, Tampa Scale of Kinesiophobia Active TENS was equally effective in terms of movement-evoked pain in patients regularly taking opioid medication and those not-regularly taking opioids.
Jamison et al.13
  • -Active wearable TENS

  • -Sham wearable TENS

PGIC, FIQR, BPI, painDETECT, PDI, HADS, PCS In the intention-to-treat population, FIQR total score, FIQR pain item, BPI Interference, and PDQ showed significant improvements for active TENS compared to sham TENS; yet, regarding PGIC, no difference was detected between groups at 3 months.
In patients with higher pain sensitivity, PGIC was significantly greater for active TENS.
Jamison et al.14
  • -Active wearable TENS

  • -Sham wearable TENS

PGIC, BPI, PDI, PCS, HADS, FIQR, painDETECT, perceived helpfulness No differences in PGIC between groups. Patients with greater hypersensitivity benefited most from TENS.
Dailey et al.15
  • -Active TENS [modulated frequency (2–125 Hz), highest tolerable intensity]

  • -Placebo TENS

  • -No TENS

Movement-evoked pain and fatigue (6-minute walk test and 5-time sit-to-stand test; NRS), pain intensity and interference (BPI), resting pain and fatigue (NRS, MAF), Pain Self-Efficacy Questionnaire, PCS, FIQ, SF-36, fear of movement(Tampa Scale of Kinesiophobia), depression and anxiety (PROMIS short forms) Greater reduction was observed in movement-evoked pain and fatigue by active TENS versus placebo TENS and versus no TENS.
Castro- Sánchez et al.17
  • -TENS (pulse width 200 µs, pulse frequency 100 Hz, burst frequency 2 Hz for 10 min for each pain dermatome)

  • -Dry needling

Short Form pain scale of the McGill Pain Questionnaire, heart rate variability, galvanic skin response, SpO2 and photoplethysmography Dry needling provided greater improvements across all dimensions of pain, higher difference for several parameters of heart rate variability and galvanic skin responses.
No between-group differences were observed in spectral analysis of the photoplethysmography and SpO2.
Scaturro et al.18
  • -LASER + TENS+ Exercise

  • -Exercise Unrelated control group disease: 10 patients with mechanical pain

FIQ, SF36, VAS pain, VAS fatigue, sleep dysfunction The combined treatment provided significant improvement in pain, fatigue, and FIQ; yet not in the SF36.
Yüksel et al.19
  • -TENS

  • -Acupuncture

Quantitative EEG changes, Pain TENS resulted an increase in the alpha power of the left anterior region.
Acupuncture resulted an increase in the alpha power of the right and left posterior regions.
Both treatments improved pain scores.
Thieme et al.20
  • -OT-TENS

  • -SET

  • -AE-BRT

Manual Tender Point Survey, MPI, NRS-pain, BRS, treatment expectation ratings and satisfaction ratings SET provided greater reduction in pain and pain interference.
Dailey et al.21
  • -Active TENS

  • -Placebo TENS

  • -No TENS

Pain and fatigue at rest (VAS), pain and fatigue in movement (VAS), Conditioned Pain Modulation, 6-m walk test, 5-time sit- to-stand test), pressure pain thresholds, range of motion, single-leg stance Compared to placebo TENS and no TENS; Active TENS improved pain and fatigue with movement; increased pressure pain thresholds; provided a significantly stronger conditioned pain modulation. Functional tasks showed no change with TENS.
Lauretti et al.22
  • -Single-TENS (1 active and 1 placebo TENS)

  • -Double-TENS (2 active TENS devices)

  • -Placebo TENS (no stimulus)

VAS pain, consumption of analgesics, quality of sleep, fatigue Pain relief, improvement in quality of sleep and disposition were double-TENS > single-TENS > placebo TENS
Carbonairo et al.23
  • -Education + AE + static stretching + TENS

  • -Education + AE + static stretching

VAS pain, tender points pain threshold, FIQ Change in pain intensity was higher in patients received TENS. Patients who did not receive TENS showed worsening of the pain threshold.
Mutlu et al.24
  • -Supervised exercise + TENS

  • -Supervised exercise

Tender point count, myalgic pain score, FIQ, SF-36 The improvement in myalgic pain was higher in the exercise+TENS group at the 3rd week, yet not different at the 12thweek.
The improvement in other outcomes was not different between groups.
Moretti et al.80 US+IFC (Once a week vs twice a week) VAS, FIQ, Post Sleep Inventory, Tender point count Both groups showed improvement in outcome measures.
No significant between-group differences.
Germano et al.71
  • -LLLT (functional exercise program associated with active phototherapy: 40 to 60’, 3 times a week for 8 weeks, 808 nm, 100 mW, 4 J, 142.85 J/cm2 per point, applied bilaterally to different points of the quadriceps, hamstrings, and triceps sural muscles immediately after each exercise session )

  • -Placebo (functional exercise program associated with placebo phototherapy)

Pain sites, pain intensity, pain threshold, balance, functional tests, muscle flexibility, isokinetic variables, depression, QoL No significant differences were observed between groups.
da Silva et al.72
  • -Phototherapy irradiation (11 locations, employing a cluster with 9 diodes (1 super-pulsed infrared 905 nm, 4 LEDs of 640 nm, and 4 LEDs of 875 nm, 39.3 J per location)

  • -Phototherapy+exercise training

  • -Exercise training and phototherapy placebo

  • -Control

Algometry, VAS-pain, FIQ and Research Diagnostic Criteria (RDC) instruments, SF-36 LEDs and exercise training improved the pain threshold. Combined therapy provided a more substantial effect.
Vayvay et al.73
  • -Low-level Ga-AS LASER, 100–240 v, 50–60 hz 75 VA, 2 J/cm2, 40 mw, wavelength: 850 nm, 3’ each on painful points+exercise

  • -Placebo LASER+exercise

  • -Taping application+exercise

VAS-pain, trunk flexibility, FIQ, SF-36, BDI In the LASER group, improvement in pain severity in activity, anxiety level, general health status, QoL was observed.
Trunk flexibility improved in the taping group.
Pain severity at night and functional status improved after all interventions.
Nakajima et al.74 Bilateral xenon light irradiation (0.38–1.1 μm) around the stellate ganglion, 15’ VAS-pain, FIQ Xenon light irradiation of the stellate ganglion provided significant improvement in pain scores in patients with a higher score in the FIQ.
Ruaro et al.75
  • -LLLT (GaAlAs LASER, 20 mW, 670nm, 4 J/cm2, 7sx4 for 18 tender points

  • -Sham

FIQ, McGill Pain Questionnaire, VAS, tender point count Although the number of tender points reduced in both groups, only LLLT provided significant improvements in FIQ, McGill Pain Questionnaire and VAS.
Panton et al.76
  • -Class IV LASER (twice weekly sessions for 4 weeks, continuous-wave, dual-wavelength LASER with 20% 810 nm, and 80% 980 nm at 10 W ) and heat therapy

  • -Sham treatment and heat therapy

Myalgic score, FIQ, CS-PFP test Compared to the sham group, LASER heat therapy significantly improved pain and FM impact measured by the FIQ and upper body flexibility measured by the CS-PFP test.
Klemm et al.85 Whole-body cryotherapy (6 sessions (−130 °C in 6 weeks) VAS-pain after 6 sessions, FIQ, VAS-pain after 3 sessions and 3 months after discontinuation of therapy, cytokine levels (IL-1, IL-6, IL-10, TNF-α), patients’ opinions on the satisfaction, effectiveness and significance of whole-body cryotherapy Whole-body cryotherapy provided a significant reduction in pain and disease activity after 3 and 6 sessions. Patients with FM revealed significantly different response of IL-1, IL-6 and Il-10 to whole-body cryotherapy.
Rivera et al.82 Cryotherapy (cryosauna cabin) vs control VAS-pain, FIQ, ICAF Following the first period, change in pain, FIQ and ICAF scores were significantly greater in the whole-body cryotherapy group.
Yilmaz et al.81 Local cold application (cold gel pack, 10’ to one trapezius muscle) VAS-pain Local cold application to the trapezius muscle providedsignificant improvement in pain.

FM: fibromyalgia; RTO: regularly taking opioids; MAF: multidimensional assessment of fatigue; US: ultrasound; IFC: interferential current; VAS: Visual Analogue Scale; FIQ: Fibromyalgia Impact Questionnaire; FIQR: Fibromyalgia Impact Questionnaire Revised; PGIC: Patient Global Impressionof Change; BPI: Brief Pain Inventory; PDQ: painDETECT questionnaire; PDI: Pain Disability Inventory; PCS: Pain Catastrophizing Scale; PROMIS: Patient-Reported Outcomes Measurement Information System; HADS: Hospital Anxiety and Depression Scale; painDETECT: Pain Detect Neuropathic Pain Questionnaire; SpO2: galvanic response and oxygen saturation; LASER: Light amplification by stimulated emission of radiation; SF-36: Short Form-36; EEG: electroencephalography; OT: Operant treatment; BRS: baroreflex sensitivity; AE: aerobic exercise; SET: systolic extinction training; MPI: Multidimensional Pain Inventory; NRS: numeric rating scale; LLLT: low-level laser therapy; IL: interleukin; TNF-α: tumor necrosis factor α; ICAF: Combined Index of Severity of Fibromyalgia; LEDs: light-emitting diodes; CS-PFP: Continuous Scale Physical Functional Performance.

Table 2.

Results of studies involving the effects transcranial direct/alternating current stimulation, transcranial magnetic stimulation, and occipital nerve stimulation for fibromyalgia-related pain.

Study Intervention(s) Stimulation area/duration Outcome measures Results
Paula et al.29
  • -LDN+tDCS

  • -LDN+tDCS Sham

  • -Placebo+tDCS

  • -Placebo+tDCS Sham

M1, 20’ VAS-pain, PCS, STAI, FIQ, BDI-II, PCP:S, PPT, CPM, BDNF serum level The LDN+tDCS group experienced improvement in pain frequency, intensity, effect of pain on activities and emotions.
Arroyo-Fernández et al.30
  • -Active tDCS+exercise

  • -Sham tDCS+exercise

  • -No-intervention

5 sessions over 2 weeks Main outcomes were pain intensity and referred pain area following suprathreshold pressure stimulation Active tDCS group experienced further improvement in pain intensity.
Compared to no-intervention, active and sham tDCS provided improvement in health status, pain catastrophising, and depression
Samartin-Veiga et al.31
  • -tDCS on left M1

  • -tDCS on left DLPFC

  • -tDCS on left OIC

  • -Sham tDCS

15 sessions of 20’ SF-36, FIQ-R Although all groups showed improvement in QoL and symptoms’ impact, no group effect or group treatment interaction was observed.
Samartin-Veiga et al.32
  • -tDCS on left M1

  • -tDCS on left DLPFC

  • -tDCS on left OIC

  • -Sham tDCS

15 sessions of 20’ Pain intensity, fatigue, mood, cognitive and sleep disorders, PPT Irrespective of the group, patients experienced significant improvement in clinical pain and for fatigue, cognitive and sleep disturbances, and experimental pain.
All active tDCS groups revealed a significantly greater improvement in anxiety and depression when compared to sham tDCS.
Caumo et al.33
  • -Home-based anodal tDCS

  • -Sham tDCS

Bifrontal, with anodal on the left DLPFC for 20’ PCS, Profile of Chronic Pain: Screen, depressive symptoms, sleep quality, heat pain threshold, heat pain tolerance, serum BDNF tDCS provided reduction in PCS scores by 51.38% when compared to 26.96% observed by sham-tDCS.
Profile of Chronic Pain: Screen total scores reduced by 31.43% in the active group, compared to 19.15% in the sham group. tDCS improved sleep quality and depressive symptoms; increased heat pain tolerance.
Matias et al.34
  • -tDCS associated with functional exercise

  • -Sham-tDCS associated with functional exercise

Left motor cortex, 5 consecutive days during the first week of intervention Pain intensity, functional performance, QoL, psychological symptoms There were no significant between-group differences in terms of the improvement in outcome measures.
Kang et al.35 tDCS 20’ on 5 consecutive days VAS-pain, FIQ, BPI, BFI, BDI, STAI, MOS-SS 46 patients experienced improvements in VAS pain scores (on days 6, 13, 36), in FIQ (on day 13), in BDI (on days 6 and 36), and in BFI (on days 6 and 13).
No significant improvement was observed in STAI-I, STAI-II, and MOS-SS scores.
Brietzke et al.36
  • -Home-based anodal tDCS

  • -Sham tDCS

Over the left DLPFC for 30’ VAS-pain, disability related to pain measured by Profile of Chronic Pain: Screen, analgesic use, psychological symptoms, sleep quality, PPT, heat pain threshold Active tDCS improved cumulative pain scores by 45.65%, following the first 20 sessions.
Active tDCS improved pain scores by 62.06% after 60 sessions. Active tDCS reduced the risk for analgesic use in 55%.
Khedr et al.37
  • -Real tDCS

  • -Sham tDCS

Over left M1, 10 sessions WPI, SS, VAS-pain, pain threshold, HAM-D and HAM-A, serum beta-endorphin level The real tDCS group experienced higher improvement in WPI, SS, VAS, pain threshold, HAM-A, HAM-D.
Serum beta-endorphin level was negatively correlated to the changes in different rating scales of pain and mood.
Silva et al.38
  • -Active tDCS

  • -Sham tDCS

Over the DLPFC, 20’ Attention Network Test, heat pain threshold, Heat pain tolerance Active tDCS provided improvement in the orienting and executive attention networks, with no effect on alertness. Active tDCS increased HPTh when compared to sham tDCS.
Mendonca et al.39
  • -tDCS + AE

  • -AE only

  • -tDCS only

Over M1, 5 days of stimulation for 20’ Pain intensity, anxiety, QoL, mood, PPT, cortical plasticity In terms of pain intensity, tDCS/AE was superior to AE alone. There was significant difference between groups in terms of anxiety and mood levels, with tDCS/AE treatment provided the greatest response.
In terms of responses in motor cortex plasticity, there was no difference among groups.
Cummiford et al.40 5 days of real tDCS and 5 days of sham tDCS Over left M1 Resting state functional connectivity There may be a placebo response to both sham and real tDCS. Yet, real tDCS caused distinct changes in functional connectivity that lasted beyond the treatment period. Stronger baseline functional connectivity between M1- ventral lateral thalamus, primary somatosensory cortices-anterior insula, and ventral lateral thalamus-periaqueductal gray predicted greater analgesia following sham and real tDCS. tDCS over M1 might produce analgesia by altering thalamic connectivity.
Castillo-Saavedra et al.41 HD-tDCS Over left M1, 20’ per session VAS-pain, pain diary, FIQ, BDI, Semmes-Weinstein Monofilament measurement, PPT, Neurophysiologic Outcomes: Contact Heat- Evoked Potentials Half of the patients experienced clinically significant benefit of a 50% pain reduction.
The median number of HD-tDCS sessions to reach clinically meaningful outcomes was estimated as 15.
Foerster et al.42 Sham tDCS (5 consecutive days), a 7-day washout, followed by active tDCS (5 consecutive days) Over left M1 Proton magnetic resonance spectroscopy Pain scores showed a significant decrease between the baseline and active tDCS time points.
Following active tDCS, compared to sham tDCS, glutamate + glutamine levels (Glx) in the anterior cingulate were significantly lower.
Baseline anterior cingulate Glx levels showed correlation with the improvement in pain score.
Fagerlund et al.43
  • -Active tDCS

  • -Sham tDCS

Over M1, 5 consecutive sessions for 20’ NRS for pain intensity, pain unpleasantness, stress, anxiety; FIQ; HADS; The SCL-90R; SF36v2 Active tDCS provided a small but significant improvement in pain when compared to sham tDCS. Yet, the results are unlikely to reflect clinically important changes.
Daily functioning improved by active tDCS group compared with the sham tDCS.
Villamar et al.44 Anodal, cathodal, and sham HD-tDCS Left M1, single 20-minute sessions VNS for pain, VNS for anxiety, Adapted QOL Scale, BDI-II, Semmes-Weinstein monofilaments for pain and mechanical detection threshold, PPT, diffuse noxious inhibitory controls Both active stimulation conditions provided significant reduction in overall perceived pain (which occurred immediately after cathodal HD-tDCS) when compared to sham.
Active anodal HD-tDCS induced a significant bilateral increase in mechanical detection thresholds.
Gómez-Arguelles et al.46 Low frequency (8 Hz) square wave with a picoTesla magnetic field The insula, DLPFC Cingulum 20 min Magnetoencephalography, FIQ, Pain threshold TMS provided an increase in alpha brain oscillatory activity particularly in the left DLPFS and an improvement in FIQ.
Pareja et al.47
  • -Standard pharmacological treatment

  • -Standard pharmacological treatment + LIMS

8 sessions of 20’ long, once a week WPI, SS score, FIQ Significant improvement was observed in WPI, SS score and FIQ from the second week following the last session.
These beneficial effects were maintained throughout the 24 weeks of follow-up after the last intervention.
Argaman et al.48
  • -Real rTMS and Sham rTMS

M1, 10 daily treatments over 2 weeks, with a washout period in between Functional connectivity FM-related symptomology Only the real rTMS provided reductions in FM-related symptomology The changes showed correlation with resting-state functional connectivity in brain areas related to pain processing and modulation.
Izquierdo-Alventosa et al.49
  • -Physical exercise

  • -High frequency TMS

  • -Control group

Over M1, 5 sessions of 20’ per week for 2 weeks VAS-pain, PPT, FIQR, 6-Minute Walking Test, CR-10 Borg scale for induced fatigue, 4-meter gait speed test, 5-repetition sit-to-stand test, HADS, BDI-II, Perceived Stress Scale-10, Satisfaction with Life Scale TMS provided significant improvement in all studied variables-except for satisfaction.
Physical exercise provided improvement in average PPT, perceived overall impact of FM and total score, endurance and functional capacity, velocity and power, anxiety, depression, and stress. Controls revealed no improvements in any outcome measures.
Forogh et al.50
  • - High-frequency rTMS

  • - Anodal tDCS

Over the left DLPFC, 3 sessions over 1 week. VAS-pain, FIQR, Depression Anxiety Stress Scale-21 Item The behavior of two treatment groups differed regarding changes in VAS-pain in favor of the rTMS group.
However, time-group interaction effect on DASS-21 and FIQR was not significant.
rTMS provided at least a 30% reduction of VAS in 66.6% of patients, while 26.6% of patients in tDCS group experienced this improvement.
Guinot et al.51
  • -Active rTMS +multicomponent therapy

  • - Sham rTMS +multicomponent therapy

  • -Multicomponent therapy alone

Over M1; induction phase: 2 weeks, 5 sessions/week, followed by maintenance phase: 12 weeks, 2 sessions on week 3 (the first week of exercise training), then 1 session/week on weeks 4, 6, 9 and 13 Weekly mean self-reported level of VAS-pain, FIQ, BDI, PSQI, PCS, cardiorespiratory fitness, cardiac autonomic adaptations There was no between-group difference in terms of the reduction of the weekly mean of pain reported daily.
rTMS added to multicomponent therapy did not improve pain.
Bilir et al.52
  • -Active rTMS

  • -Sham rTMS

Over the left DLPFC; induction phase: 10 sessions daily, 5 days per week for 2 weeks followed by maintenance phase: 4 sessions weekly, 1 day per week for 4 weeks VAS-pain, FIQ, Fatigue Severity Scale, HADS, Addenbrooke’s cognitive examination-last revised version, VAS-stiffness VAS-pain, Fatigue Severity Scale and HADS scores did not differ within or between groups over time.
rTMS provided significant improvement in VAS-stiffness and FIQ at the 2nd week. Yet, no significant between-group difference was detected.
Tanwar et al.53
  • -Real rTMS

  • -Sham rTMS

Over the right DLPFC, 5 consecutive days per week for 4 weeks Numerical Pain Rating Scale, MPQ, Hamilton Depression Rating Scale, Hamilton Anxiety Rating Scale, WHOQOL-Quality of Life-BREF questionnaire, nociceptive flexion reflex, pain modulation, estimation of oxidative stress markers Real-rTMS provided significant improvement in average pain ratings and associated symptoms.
The improvements lasted up to 6 months.
Sham-rTMS group provided no significant change in pain ratings.
Altas et al.54
  • -High frequency rTMS to left M1

  • - High frequency rTMS to left DLPFC

  • -Sham rTMS

15 sessions over 3 weeks, 10 Hz VAS, FIQ, Fatigue Severity Scale, SF-36, BDI Active rTMS provided greater improvement in depression, physical functioning, physical role functioning, and general health perceptions.
Active rTMS over M1 provided greater improvement in VAS pain compared to sham rTMS.
Active rTMS over DLPFC provided greater change in physical role functioning compared to active rTMS over M1.
An improvement in emotional functioning was observed only by active rTMS over M1.
Abd Elghany et al.55
  • -rTMS

  • -Prolotherapy

rTMS sessions every other day for one month VAS-pain, BDI, FIQ revised, cortical auditory evoked potentials, number of tender points In the prolotherapy group compared to rTMS group, improvement in VAS-pain was remarked; difference in number of tender points and revised FIQ score were significant immediately after treatment and one month later.
BID and cortical auditory evoked potentials showed better improvement in the rTMS group compared to the prolotherapy group.
Fitzgibbon et al.56
  • -Active rTMS

  • -Sham rTMS

Left-hemisphere DLPFC, daily sessions over 4 weeks SF-MPQ, BPI short form, NRS pain intensity and pain unpleasantness, SF-36v2, FIQ, Multidimensional Fatigue Inventory-20, PCS, BDI-II, BAI, Patients’ Global Impression of Change scale By active rTMS, physical fatigue and general fatigue improved significantly.
The active group had 2.84 times more chance to experience a minimum 30% improvement in pain intensity.
Yet, no group difference for the primary outcome measures was observed.
Tzabazis et al.57 rTMS Different configurations of rTMS, 20 daily sessions of 30’ over 4 weeks were applied to the FM group BPI, FIQ, BDI-II, NRS In patients with fibromyalgia, rTMS, operated at 10 Hz, provided 43% reduction in NRS pain over last 24 hours.
This improvement was maintained for at least 4 weeks following the final session.
Maestú et al.58
  • -Very low intensity TMS

  • -Sham TMS

One session (20’) per week for 8 weeks. PPT, Blood serotonin level, VAS for ability to perform daily activities, perceived chronic pain intensity, fatigue, anxiety, depression, sleep quality, and severity of headaches When compared to controls, active group revealed significant improvement in somatosensory pain thresholds, ability to perform daily activities, perceived chronic pain and sleep quality.
Yet, scores of depression, fatigue, severity of headaches, as well as serotonin levels were not different between two groups.
Lee et al.59
  • -Low-frequency (1 Hz) rTMS to right DLPC

  • -High-frequency (10 Hz) rTMS to left M1

  • -Sham stimulation

10 consecutive sessions Number of tender points, FIQ, VAS-pain, BDI Immediately after low-frequency rTMS, VAS-pain and FIQ scores decreased significantly.
One month after low-frequency rTMS, BDI scores decreased significantly from baseline.
Immediately after high-frequency rTMS, VAS-pain and BDI scores decreased significantly.
Baudic et al.60
  • -Active rTMS

  • -Sham rTMS

Left M1, 14 stimulation sessions over 21 weeks BPI, MOS-SF-12, HADS No between-group difference in overall neuropsychological performance was detected.
Lin et al.61
  • -Active HD-tACS

  • -Sham stimulation

Left M1 10 sessions in 2 weeks NRS-pain intensity, FIQ, BAI and BDI-II, PSQI, PPT, total Tau and Beta-Amyloid 1–42 Although improvement in FIQ was detected after HD-tACS, no significant difference was observed in NRS and FIQ scores compared to sham stimulation.
Although most adverse events were mild, one patient in HD-tACS group attempted suicide during the study.
Ahmed et al.65
  • -Active occipital nerve field stimulation

  • -Device turned-off

Implanted subcutaneous electrode, sub-sensory threshold stimulation for 2 weeks FIQ, Pain Vigilance and Awareness Questionnaire, PCS, NRS, H215O PET scans, EEG data Active occipital nerve stimulation led to an activation in the DLPFC. EEG data revealed increased activity in the descending pain pathway.
Occipital nerve stimulation was shown to exert its effects by the activation of the descending pain inhibitory pathway and the lateral pain pathway.
Yoo et al.66
  • -Control with sham occipital stimulation

  • -tDCS on the occipital nerve (ON) only

  • -tDCS on bilateral DLPFC before occipital stimulation

8 sessions for 4 weeks, the sessions were 3 days apart from each other FIQ, BDI, NRS-pain Adding bifrontal tDCS to ONS has no added benefit in improving outcomes.
To et al.67
  • -tDCS over C2 area

  • -tDCS over DLPFC

  • -Sham tDCS

Over C2 area or DLPFC, 8 sessions: two times a week for 4 weeks NRS, PCS, Modified Fatigue Impact Scale tDCS to C2 area provided significant improvement in pain, but not in fatigue.
tDCS over DLPFC significantly improved pain and fatigue.
Ridder and Vanneste68
  • -Occipital nerve field tDCS and Sham tDCS

Over C2 area; 1 consecutive week of sham tDCS and 1 week of active tDCS with a 2-week washout between the sham and active tDCS NRS, FIQ, EEG data Active occipital nerve field tDCS (but not sham protocol) improved dysfunctional effective connectivity from the pregenual anterior cingulate cortex to the dorsal anterior cingulate cortex.
Plazier et al.69 C2 nerve field stimulation Implanted subcutaneous electrode in the C2 dermatoma; different doses of stimulation for 2 weeks FIQ, Pain Vigilance and Awareness Questionnaire, PCS, tender point examination, NRS for pain and QoL, overall satisfaction, QoL, and overall symptom relief, BDI, Modified Fatigue Impact Scale, PSQI Patients experienced an overall decrease of 36% and 33% on FIQ and pain, respectively.
Daily life activities and quality improved by 42% during the first 6 weeks. The results maintained at 6 months follow up.
Higher amplitudes seemed to provide better outcomes.
Plazierlaser et al.70 Greater occipital nerve stimulation Implanted subcutaneous occipital nerve stimulator FIQ, pain threshold, Laser-Evoked Potentials recordings Despite a significant increase in N2P2 latencies (particularly at the Pz electrode), the amplitudes of the LEP recordings were not modified by occipital nerve stimulation.

FM: fibromyalgia; tDCS: transcranial direct current stimulation; HD-tACS: high-definition transcranial alternating current stimulation; M1: Primary motor cortex; NRS: numeric rating scale; FIQ: fibromyalgia impact questionnaire; BAI: Beck Anxiety Inventory; BDI-II: Beck Depression Inventory Second Edition; PSQI: Pittsburgh Sleep Quality Index; PPT: pressure pain threshold; DLPFC: dorsolateral prefrontal cortex; LDN: low-dose naltrexone; VAS: Visual Analog Scale; PCS: Pain Catastrophizing Scale; STAI: State-Trait Anxiety Inventory; PCP:S: Profile of Chronic Pain Scale; CPM: Conditioned Pain Modulation; SF-36: Short form 36; OIC: operculo-insular cortex; BPI: Brief Pain Inventory; BFI: Brief Fatigue Inventory; MOS-SS: Medical Outcomes Study Sleep Scale; ONS: occipital nerve stimulation; WPI: widespread pain index; SS: symptom severity of fibromyalgia; HAM-D: Hamilton depression scale; HAM-A: Hamilton anxiety scale; AE: aerobic exercise; HD-tDCS: high-definition transcranial direct current stimulation; SCL-90R: The Symptom Checklist-90-Revised; VNS: visual numbering scale; rTMS: repetitive transcranial magnetic stimulation; SF-MPQ: Short-Form McGill Pain Questionnaire; MOS-SF-12: Medical Outcomes Study Short Form 12; BNDF: brain-derived-neurotrophic-factor; LIMS: low-intensity magnetic stimulation; EEG: electroencephalography; PET: positron emission tomography.

Non-invasive brain stimulation techniques have been widely studied in fibromyalgia. Non-invasive brain stimulation techniques include transcranial direct current stimulation (tDCS),29–45 transcranial magnetic stimulation (TMS),46–60 high-definition transcranial alternating current stimulation (HD-tACS),61 cranial electrotherapy stimulation, transcranial random noise stimulation and reduced impedance non-invasive cortical electrostimulation.62 These stimulation techniques alter the excitability of the certain areas of the brain. The most commonly studied application areas are the primary motor cortex (M1) and the dorsolateral prefrontal cortex.63 A Cochrane review by O’Connell et al. concluded that, with very low-quality evidence, single doses of high-frequency rTMS of the motor cortex and tDCS may provide short-term benefits on chronic pain and quality of life among patients with fibromyalgia. The authors could not obtain similar benefit regarding low-frequency rTMS, rTMS applied to the dorsolateral pre-frontal cortex and cranial electrotherapy stimulation.62 After then, research on that topic has continued. For instance, Pareja et al. investigated the effects of transcranial low-intensity magnetic stimulation in women with fibromyalgia.47 After eight weeks of treatment, significant improvement in diagnostic variables were obtained. Moreover, the beneficial effects maintained up to 24 weeks after the last treatment session.47 Gomez-Arguelles et al. also reported favourable results by using low intensity TMS.46 Argaman et al. reported an association between the functional alterations of brain areas playing role in the experience of chronic pain and the acute clinical effects of rTMS of the motor cortex.48 Nevertheless, high-frequency rTMS to the left dorsolateral prefrontal cortex did not provide benefits on fibromyalgia-related symptoms.52

A randomised controlled trial by Izquierdo-Alventosa et al. investigated the effects of high-frequency TMS and physical exercise in women with fibromyalgia. Results showed similar benefits of TMS and exercise for physical status, whilst TMS provided more improvement than exercise for emotional status.49 Guinot et al. compared the effects of rTMS (high-frequency, primary motor cortex M1) and sham rTMS with a combination of 12-week multicomponent therapy.51 They found no significant difference between groups in terms of weekly mean of pain reported daily.51 Izquierdo-Alventosa found that TMS provided similar improvement in physical status when compared to low-intensity physical exercise program. However, in terms of emotional status, TMS provided greater benefit.49 A recent systematic review and meta-analysis investigating 7 studies with 217 patients concluded that 10-Hz rTMS can significantly improve pain and quality of life in patients with fibromyalgia.64 Moreover, a subgroup analysis based on stimulation at the primary motor cortex and dorsolateral prefrontal cortex revealed no significant difference.64 Forogh et al. performed a comparative analysis of rTMS and tDCS. Although both modalities appeared as safe treatment options, rTMS over dorsolateral prefrontal cortex provided greater and longer pain relief effect.50

Home-based electrical stimulation has also been studied recently.33,36 A randomised, double-blind, sham-controlled study showed that home-based bifrontal tDCS with a-tDCS on the left dorsolateral prefrontal cortex provided a decrease in rumination/magnification of pain catastrophising and improvement in the disability for daily activities due to fibromyalgia-related symptoms. Data derived from the trial supported the feasibility of a self-applied home-based version of tDCS.33 Another type of stimulation attracted attention in fibromyalgia is the occipital nerve stimulation, which can be performed by tDCS or implanted electrode.65–70 The results of the studies involving the effects of tDCS, TMS, HD-tACS, occipital nerve stimulation for fibromyalgia-related pain are provided in Table 2.

Light has been used as a therapeutic option in several musculoskeletal disorders. Over the lats decade, the potential effects of light have also been studied for fibromyalgia-related pain (Table 1).71–76 Photobiomodulation therapy is a non-thermal and non-ionising light therapy, which is applied in the form of Light Amplification by Stimulated Emission of Radiation (LASER) and red and/or near infrared low-intensity light-emitting diodes (LEDs).8 LASER, which is usually applied on tender points may provide some benefits in terms of pain relief.63 Ruaro et al. showed the beneficial effects of low-level laser therapy (LLLT) in pain relief among patients with fibromyalgia.75 Panton et al. also obtained favourable results; Class IV LASER therapy provided benefits in improving pain and upper body range of motion.76 There are studies evaluated the effects of LASER in orofacial pain or temporomandibular pain in patients with fibromyalgia.77,78 A randomised controlled trial by Molina-Torres et al. evaluated the effectiveness of LASER therapy applied to the tender points and of an occlusal stabilisation splint in patients with temporomandibular disorders and fibromyalgia.78 Both appeared as alternative therapeutic options for improving pain and the clicking sound for temporomandibular disorders.78 From a different point of view, add-on LLLT to exercise is used in healthy people to increase muscle performance and to avoid exercise-induced fatigue. However, there is conflicting data regarding the patients with fibromyalgia.63 In a double-blind, placebo-controlled randomised clinical trial evaluating the effects of LLLT combined to an exercise program in patients with fibromyalgia, LLLT was performed onto quadriceps, hamstrings and triceps sural muscles for 40–60 minutes, 3 times/week for 8 weeks immediately after the exercise. Low-level laser therapy failed to further improve the beneficial effects of functional exercise.71 Dos Santos et al. also reported that peripheral muscle strength and resistance did not show improvement following acute LLLT application.79

With regard to other physical modalities, combined therapy composed of ultrasound and interferential current has been studied in patients with fibromyalgia.80 Moretti et al. used 4000 Hz of current carrier, 100 Hz of amplitude-modulated frequency for interferential therapy and 1 MHz pulsed ultrasound at 20% of 2.5 W/cm².80 Patients were randomised in two groups; one group was treated once a week and the other was treated twice a week. Both groups showed improvement in visual analogue scale, tender points, Fibromyalgia Impact Questionnaire and Post Sleep Inventory. Yet, groups did not show difference in terms of generalised pain, quality of life and sleep quality (Table 1).80 The application of therapeutic heat/cold is a common technique used for painful musculoskeletal conditions. There are favourable results regarding the effectiveness of cold application and whole-body cryotherapy in fibromyalgia-related pain and/or quality of life.81–83 These results might be related to the anti-inflammatory effects of cold therapy, as there is cumulative evidence regarding the role of inflammation in fibromyalgia.84 In this regard, whole-body cryotherapy was suggested to modulate several neurotransmitters and cytokines, which might play role in pain alleviation.85 Klemm et al. evaluated whether clinical effects of whole-body cryotherapy in fibromyalgia could be explained by changes in cytokine levels. They found that IL-1, IL-6 and IL-10 levels were significantly altered over time. Moreover, patients with fibromyalgia demonstrated a significantly different response of IL-1, IL- 6 and IL- 10 to whole-body cryotherapy when compared to controls (Table 1).85 The use of extracorporeal shockwave therapy (ESWT) in fibromyalgia is controversial. Ramon et al. suggested the use of radial ESWT on each tender or trigger point for the treatment of the myofascial component of pain in fibromyalgia. Yet, they also recommended that a comprehensive supervised exercise should accompany the ESWT therapy.86

The pathophysiological mechanisms by which physical modalities alleviate pain

Physical modalities can act as counterirritant stimulus, decrease muscle spasm, and reduce the nociceptive input. For instance, TENS and interferential current can temporarily reduce pain by serving as counterirritant stimuli, which correspond to the “gate control theory” of pain. This theory suggests that non-painful sensory inputs, such as electrical stimulation, can inhibit pain signals at the spinal cord level. Electrical muscle stimulation also leads to muscle contractions that may reduce spasms, improve muscle strength, and promote blood flow to the applied area. Superficial heat can temporarily reduce pain by acting as a counterirritant stimulus and increasing soft tissue extensibility. Physical modalities such as cryotherapy (cold packs, whole body cryotherapy) are thought to reduce inflammation. They promote local vasoconstriction and can thereby decrease inflammation. Phonophoresis, as a specific therapeutic approach, can facilitate the absorption of topical agents such as analgesic and/or anti-inflammatory gels; thus, can further alleviate pain and reduce inflammation when used with these agents.87

Application of physical modalities and contraindications

Physical modalities are best used as adjunctive treatments and generally are not prescribed as stand-alone treatments. Instead, they usually accompany an exercise program, which is strongly recommended for the management of fibromyalgia by EULAR.2, 88 The application duration varies based on the type of physical modality applied. For example, TENS is generally used for 15–30 minutes per session.87 On the other hand, the duration is much less for LASER. There are several contraindications of physical modalities. Electrotherapeutic modalities such as TENS and interferential current are contraindicated in specific areas, including the anterior cervical region, heart, carotid sinuses, regions with anaesthesia, transthoracic area, and the abdomen of pregnant individuals. These treatments are also contraindicated for patients with a cardiac pacemaker, implanted defibrillator, other electrical devices, or those with venous/arterial thrombosis or thrombophlebitis. Physical modalities should not be applied over areas with malignancy, haemorrhage, infection, or ischemia, and on recently irradiated areas. Application of US on epiphyseal growth plates in skeletally immature patients, thrombotic regions, the eyes, gonads, and the spinal cord post-laminectomy is also contraindicated. Superficial heat is contraindicated in acute injuries/inflammation, haemorrhage, malignancy, impaired sensation, thrombophlebitis, or over the abdomen in pregnancy. Cold application is contraindicated in conditions like urticaria, cryoglobulinemia, Raynaud’s disease/phenomenon, paroxysmal cold haemoglobinuria, and areas with circulatory compromise, deep open wounds, or impaired somatosensory discrimination.87 The list can be extended depending on the physical modality applied.87

CONCLUDING REMARKS AND FUTURE PERSPECTIVES

There are reports and growing evidence regarding the effectiveness of several physical modalities in fibromyalgia. Nevertheless, the evidence regarding many others is still scarce. In this regard, performing research focusing on the effectiveness and safety of physical modalities in patients with fibromyalgia would be of great value.

CONFLICTS OF INTEREST

The author declares no conflicts of interest regarding the publication of this article.

FUNDING INFORMATION

None to report.

ETHICAL APPROVAL

This article does not contain any studies with human participants or animals performed by the author.

DISCLAIMER

No part of this manuscript is copied or published elsewhere in whole or in part.

REFERENCES

  • 1.Coskun Benlidayi I. Fibromyalgia as a challenge for patients and physicians. Rheumatol Int 2018;38:2345. [DOI] [PubMed] [Google Scholar]
  • 2.Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2017;76:318–28. [DOI] [PubMed] [Google Scholar]
  • 3.O’Young BJ, Young MA, Meyers JS, Stiens SA. Physical Modalities: Adjunctive Treatments to Reduce Pain and Maximize function. In Pain Management Secrets (Third Edition), Editors: Argoff CE, McCleane G; Mosby; 2009, P342–350, ISBN 9780323040198. doi: 10.1016/B978-0-323-04019-8.00044-5 [DOI] [Google Scholar]
  • 4.Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 2011;31:1409–17. [DOI] [PubMed] [Google Scholar]
  • 5.Poitras S, Brosseau L. Electrotherapeutic Modalities and Physical Agents. In: Evidence-Based Management of Low Back Pain. Editors: Dagenais S, Haldeman S. Mosby; 2012, Pages 188–204, ISBN 9780323072939, doi: 10.1016/B978-0-323-07293-9.00014-3 [DOI] [Google Scholar]
  • 6.National Guideline Centre (UK) . Evidence review for electrical physical modalities for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review H. London: National Institute for Health and Care Excellence (NICE); 2021. Apr. (NICE Guideline, No. 193.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK569985/ [PubMed] [Google Scholar]
  • 7.Lubrano E, Mazas PF, Freiwald J, Krüger K, Grattagliano I, Mur E, et al. An International Multidisciplinary Delphi-Based Consensus on Heat Therapy in Musculoskeletal Pain. Pain Ther 2023;12:93–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.DE Oliveira MF, Johnson DS, Demchak T, Tomazoni SS, Leal-Junior EC. Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal conditions. Eur J Phys Rehabil Med 2022;58:282–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ebadi S, Ansari NN, Naghdi S, Jalaei S, Sadat M, Bagheri H, et al. The effect of continuous ultrasound on chronic non-specific low back pain: a single blind placebo-controlled randomized trial. BMC Musculoskelet Disord 2012;13:192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bidonde J, Busch AJ, Schachter CL, Webber SC, Musselman KE, Overend TJ, et al. Mixed exercise training for adults with fibromyalgia. Cochrane Database Syst Rev 2019. May 24;5(5):CD013340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bidonde J, Busch AJ, Schachter CL, Overend TJ, Kim SY, Góes SM, et al. Aerobic exercise training for adults with fibromyalgia. Syst Rev 2017. Jun 21;6(6):CD012700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dailey DL, Vance CGT, Chimenti R, Rakel BA, Zimmerman MB, Williams JM, et al. The Influence of Opioids on Transcutaneous Electrical Nerve Stimulation Effects in Women With Fibromyalgia. J Pain 2022;23:1268–81. [DOI] [PubMed] [Google Scholar]
  • 13.Jamison RN, Edwards RR, Curran S, Wan L, Ross EL, Gilligan CJ, et al. Effects of Wearable Transcutaneous Electrical Nerve Stimulation on Fibromyalgia: A Randomized Controlled Trial. J Pain Res 2021;14:2265–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jamison RN, Curran S, Wan L, Ross EL, Gilligan CJ, Edwards RR. Higher Pain Sensitivity Predicts Efficacy of a Wearable Transcutaneous Electrical Nerve Stimulation Device for Persons With Fibromyalgia: A Randomized Double-Blind Sham-Controlled Trial. Neuromodulation 2022;25:1410–20. [DOI] [PubMed] [Google Scholar]
  • 15.Dailey DL, Vance CGT, Rakel BA, Zimmerman MB, Embree J, Merriwether EN, et al. Transcutaneous Electrical Nerve Stimulation Reduces Movement-Evoked Pain and Fatigue: A Randomized, Controlled Trial. Arthritis Rheumatol 2020;72:824–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Vance CGT, Zimmerman MB, Dailey DL, Rakel BA, Geasland KM, Chimenti RL, et al. Reduction in movement-evoked pain and fatigue during initial 30-minute transcutaneous electrical nerve stimulation treatment predicts transcutaneous electrical nerve stimulation responders in women with fibromyalgia. Pain 2021;162:1545–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Castro-Sánchez AM, Garcia-López H, Fernández-Sánchez M, Perez-Marmol JM, Leonard G, Gaudreault N, et al. Benefits of dry needling of myofascial trigger points on autonomic function and photoelectric plethysmography in patients with fibromyalgia syndrome. Acupunct Med 2020;38:140–9. [DOI] [PubMed] [Google Scholar]
  • 18.Scaturro D, Guggino G, Tumminelli LG, Ciccia F, Letizia Mauro G. An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia. Clin Exp Rheumatol 2019;37:670–5. [PubMed] [Google Scholar]
  • 19.Yüksel M, Ayaş Ş, Cabıoğlu MT, Yılmaz D, Cabıoğlu C. Quantitative Data for Transcutaneous Electrical Nerve Stimulation and Acupuncture Effectiveness in Treatment of Fibromyalgia Syndrome. Evid Based Complement Alternat Med 2019;2019:9684649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Thieme K, Meller T, Evermann U, Malinowski R, Mathys MG, Graceley RH, et al. Efficacy of Systolic Extinction Training in Fibromyalgia Patients With Elevated Blood Pressure Response to Stress: A Tailored Randomized Controlled Trial. Arthritis Care Res (Hoboken) 2019;71:678–88. [DOI] [PubMed] [Google Scholar]
  • 21.Dailey DL, Rakel BA, Vance CGT, Liebano RE, Amrit AS, Bush HM, et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain 2013;154:2554–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lauretti GR, Chubaci EF, Mattos AL. Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatol Int 2013;33:2117–22. [DOI] [PubMed] [Google Scholar]
  • 23.Carbonario F, Matsutani LA, Yuan SL, Marques AP. Effectiveness of high-frequency transcutaneous electrical nerve stimulation at tender points as adjuvant therapy for patients with fibromyalgia. Eur J Phys Rehabil Med 2013;49:197–204. [PubMed] [Google Scholar]
  • 24.Mutlu B, Paker N, Bugdayci D, Tekdos D, Kesiktas N. Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatol Int 2013;33:649–55. [DOI] [PubMed] [Google Scholar]
  • 25.Eken A, Kara M, Baskak B, Baltacı A, Gökçay D. Differential efficiency of transcutaneous electrical nerve stimulation in dominant versus nondominant hands in fibromyalgia: placebo-controlled functional near-infrared spectroscopy study. Neurophotonics 2018;5:011005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chimenti RL, Rakel BA, Dailey DL, Vance CGT, Zimmerman MB, Geasland KM, et al. Test-Retest Reliability and Responsiveness of PROMIS Sleep Short Forms Within an RCT in Women With Fibromyalgia. Front Pain Res (Lausanne) 2021;2:682072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Vance CG, Chimenti RL, Dailey DL, Hadlandsmyth K, Zimmerman MB, Geasland KM, et al. Development of a method to maximize the transcutaneous electrical nerve stimulation intensity in women with fibromyalgia. J Pain Res 2018;11:2269–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Johnson MI, Claydon LS, Herbison GP, Jones G, Paley CA. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev 2017;10:CD012172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Paula TMH, Castro MS, Medeiros LF, Paludo RH, Couto FF, Costa TRD, et al. Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial. Braz J Anesthesiol 2023;73:409–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Arroyo-Fernández R, Avendaño-Coy J, Velasco-Velasco R, Palomo-Carrión R, Bravo-Esteban E, Ferri-Morales A. Effectiveness of Transcranial Direct Current Stimulation Combined With Exercising in People With Fibromyalgia: A Randomized Sham-Controlled Clinical Trial. Arch Phys Med Rehabil 2022;103:1524–32. [DOI] [PubMed] [Google Scholar]
  • 31.Samartin-Veiga N, González-Villar AJ, Pidal-Miranda M, Vázquez-Millán A, Carrillo-de-la-Peña MT. Active and sham transcranial direct current stimulation (tDCS) improved quality of life in female patients with fibromyalgia. Qual Life Res 2022;31:2519–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Samartin-Veiga N, Pidal-Miranda M, González-Villar AJ, Bradley C, Garcia-Larrea L, O’Brien AT, et al. Transcranial direct current stimulation of 3 cortical targets is no more effective than placebo as treatment for fibromyalgia: a double-blind sham-controlled clinical trial. Pain 2022;163:e850–e861. [DOI] [PubMed] [Google Scholar]
  • 33.Caumo W, Alves RL, Vicuña P, Alves CFDS, Ramalho L, Sanches PRS, et al. Impact of Bifrontal Home-Based Transcranial Direct Current Stimulation in Pain Catastrophizing and Disability due to Pain in Fibromyalgia: A Randomized, Double-Blind Sham-Controlled Study. J Pain 2022;23:641–56. [DOI] [PubMed] [Google Scholar]
  • 34.Matias MGL, Germano Maciel D, França IM, Cerqueira MS, Silva TCLA, Okano AH, et al. Transcranial Direct Current Stimulation Associated With Functional Exercise Program for Treating Fibromyalgia: A Randomized Controlled Trial. Arch Phys Med Rehabil 2022;103:245–54. [DOI] [PubMed] [Google Scholar]
  • 35.Kang JH, Choi SE, Park DJ, Xu H, Lee JK, Lee SS. Effects of add-on transcranial direct current stimulation on pain in Korean patients with fibromyalgia. Sci Rep 2020;10:12114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Brietzke AP, Zortea M, Carvalho F, Sanches PRS, Silva DPJ, Torres ILDS, et al. Large Treatment Effect With Extended Home-Based Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex in Fibromyalgia: A Proof of Concept Sham-Randomized Clinical Study. J Pain 2020;21:212–24. [DOI] [PubMed] [Google Scholar]
  • 37.Khedr EM, Omran EAH, Ismail NM, El-Hammady DH, Goma SH, Kotb H, et al. Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: A double blinded, randomized clinical trial. Brain Stimul 2017;10:893–901. [DOI] [PubMed] [Google Scholar]
  • 38.Silva AF, Zortea M, Carvalho S, Leite J, Torres IL, Fregni F, et al. Anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex modulates attention and pain in fibromyalgia: randomized clinical trial. Sci Rep 2017;7:135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mendonca ME, Simis M, Grecco LC, Battistella LR, Baptista AF, Fregni F. Transcranial Direct Current Stimulation Combined with Aerobic Exercise to Optimize Analgesic Responses in Fibromyalgia: A Randomized Placebo-Controlled Clinical Trial. Front Hum Neurosci 2016;10:68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Cummiford CM, Nascimento TD, Foerster BR, Clauw DJ, Zubieta JK, Harris RE, et al. Changes in resting state functional connectivity after repetitive transcranial direct current stimulation applied to motor cortex in fibromyalgia patients. Arthritis Res Ther 2016;18:40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Castillo-Saavedra L, Gebodh N, Bikson M, Diaz-Cruz C, Brandao R, Coutinho L, et al. Clinically Effective Treatment of Fibromyalgia Pain With High-Definition Transcranial Direct Current Stimulation: Phase II Open-Label Dose Optimization. J Pain 2016;17:14–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Foerster BR, Nascimento TD, DeBoer M, Bender MA, Rice IC, Truong DQ, et al. Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia. Arthritis Rheumatol 2015;67:576–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Fagerlund AJ, Hansen OA, Aslaksen PM. Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain 2015;156:62–71. [DOI] [PubMed] [Google Scholar]
  • 44.Villamar MF, Wivatvongvana P, Patumanond J, Bikson M, Truong DQ, Datta A, et al. Focal modulation of the primary motor cortex in fibromyalgia using 4×1-ring high-definition transcranial direct current stimulation (HD-tDCS): immediate and delayed analgesic effects of cathodal and anodal stimulation. J Pain 2013;14:371–83. [DOI] [PubMed] [Google Scholar]
  • 45.Santos VSDSD, Zortea M, Alves RL, Naziazeno CCDS, Saldanha JS, Carvalho SDCR, et al. Cognitive effects of transcranial direct current stimulation combined with working memory training in fibromyalgia: a randomized clinical trial. Sci Rep 2018;8:12477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gomez-Arguelles JM, Lopez I, Rodriguez-Rojo IC, Romero V, Sabater C, Corral M, et al. Modification of Alpha Brain Oscillatory Activity in Fibromyalgia After Very Low Intensity Transcranial Magnetic Stimulation. Pain Physician 2022;25:E831–E840. [PubMed] [Google Scholar]
  • 47.Pareja JL, Cáceres O, Zambrano P, Martín F, Berral FJ, Blanco M. Treatment with low-intensity transcranial magnetic stimulation in women with fibromyalgia improves diagnostic variables up to 6 months after treatment completion. Clin Exp Rheumatol 2022;40:1112–8. [DOI] [PubMed] [Google Scholar]
  • 48.Argaman Y, Granovsky Y, Sprecher E, Sinai A, Yarnitsky D, Weissman-Fogel I. Clinical Effects of Repetitive Transcranial Magnetic Stimulation of the Motor Cortex Are Associated With Changes in Resting-State Functional Connectivity in Patients With Fibromyalgia Syndrome. J Pain 2022;23:595–615. [DOI] [PubMed] [Google Scholar]
  • 49.Izquierdo-Alventosa R, Inglés M, Cortés-Amador S, Gimeno-Mallench L, Sempere-Rubio N, Serra-Añó P. Effectiveness of High-Frequency Transcranial Magnetic Stimulation and Physical Exercise in Women With Fibromyalgia: A Randomized Controlled Trial. Phys Ther 2021;101:pzab159. [DOI] [PubMed] [Google Scholar]
  • 50.Forogh B, Haqiqatshenas H, Ahadi T, Ebadi S, Alishahi V, Sajadi S. Repetitive transcranial magnetic stimulation (rTMS) versus transcranial direct current stimulation (tDCS) in the management of patients with fibromyalgia: A randomized controlled trial. Neurophysiol Clin 2021;51:339–47. [DOI] [PubMed] [Google Scholar]
  • 51.Guinot M, Maindet C, Hodaj H, Hodaj E, Bachasson D, Baillieul S, et al. Effects of Repetitive Transcranial Magnetic Stimulation and Multicomponent Therapy in Patients With Fibromyalgia: A Randomized Controlled Trial. Arthritis Care Res (Hoboken) 2021;73:449–58. [DOI] [PubMed] [Google Scholar]
  • 52.Bilir I, Askin A, Sengul I, Tosun A. Effects of High-Frequency Neuronavigated Repetitive Transcranial Magnetic Stimulation in Fibromyalgia Syndrome: A Double-Blinded, Randomized Controlled Study. Am J Phys Med Rehabil 2021;100:138–46. [DOI] [PubMed] [Google Scholar]
  • 53.Tanwar S, Mattoo B, Kumar U, Bhatia R. Repetitive transcranial magnetic stimulation of the prefrontal cortex for fibromyalgia syndrome: a randomised controlled trial with 6-months follow up. Adv Rheumatol 2020;60:34. [DOI] [PubMed] [Google Scholar]
  • 54.Altas EU, Askin A, Beşiroğlu L, Tosun A. Is high-frequency repetitive transcranial magnetic stimulation of the left primary motor cortex superior to the stimulation of the left dorsolateral prefrontal cortex in fibromyalgia syndrome? Somatosens Mot Res 2019;36:56–62. [DOI] [PubMed] [Google Scholar]
  • 55.Abd Elghany SE, Al Ashkar DS, El-Barbary AM, El Khouly RM, Aboelhawa MA, Nada DW, et al. Regenerative injection therapy and repetitive transcranial magnetic stimulation in primary fibromyalgia treatment: A comparative study. J Back Musculoskelet Rehabil 2019;32:55–62. [DOI] [PubMed] [Google Scholar]
  • 56.Fitzgibbon BM, Hoy KE, Knox LA, Guymer EK, Littlejohn G, Elliot D, et al. Evidence for the improvement of fatigue in fibromyalgia: A 4-week left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation randomized-controlled trial. Eur J Pain 2018;22:1255–67. [DOI] [PubMed] [Google Scholar]
  • 57.Tzabazis A, Aparici CM, Rowbotham MC, Schneider MB, Etkin A, Yeomans DC. Shaped magnetic field pulses by multi-coil repetitive transcranial magnetic stimulation (rTMS) differentially modulate anterior cingulate cortex responses and pain in volunteers and fibromyalgia patients. Mol Pain 2013;9:33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Maestú C, Blanco M, Nevado A, Romero J, Rodríguez-Rubio P, Galindo J, et al. Reduction of pain thresholds in fibromyalgia after very low-intensity magnetic stimulation: a double-blinded, randomized placebo-controlled clinical trial. Pain Res Manag 2013;18:e101–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Lee SJ, Kim DY, Chun MH, Kim YG. The effect of repetitive transcranial magnetic stimulation on fibromyalgia: a randomized sham-controlled trial with 1-mo follow-up. Am J Phys Med Rehabil 2012;91:1077–85. [DOI] [PubMed] [Google Scholar]
  • 60.Baudic S, Attal N, Mhalla A, Ciampi de Andrade D, Perrot S, Bouhassira D. Unilateral repetitive transcranial magnetic stimulation of the motor cortex does not affect cognition in patients with fibromyalgia. J Psychiatr Res 2013;47:72–7. [DOI] [PubMed] [Google Scholar]
  • 61.Lin AP, Chiu CC, Chen SC, Huang YJ, Lai CH, Kang JH. Using High-Definition Transcranial Alternating Current Stimulation to Treat Patients with Fibromyalgia: A Randomized Double-Blinded Controlled Study. Life (Basel) 2022;12:1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.O’Connell NE, Marston L, Spencer S, DeSouza LH, Wand BM. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev 2018;3:CD008208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Coskun Benlidayi I. The effectiveness and safety of electrotherapy in the management of fibromyalgia. Rheumatol Int 2020;40:1571–80. [DOI] [PubMed] [Google Scholar]
  • 64.Zhu PA, Xie JY, Liu H, Wen Y, Shao YJ, Bao X. Efficacy of High-Frequency Repetitive Transcranial Magnetic Stimulation at 10 Hz in Fibromyalgia: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil 2023;104:151–9. [DOI] [PubMed] [Google Scholar]
  • 65.Ahmed S, Plazier M, Ost J, Stassijns G, Deleye S, Ceyssens S, et al. The effect of occipital nerve field stimulation on the descending pain pathway in patients with fibromyalgia: a water PET and EEG imaging study. BMC Neurol 2018;18:191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Yoo HB, Ost J, Joos W, Van Havenbergh T, De Ridder D, Vanneste S. Adding Prefrontal Transcranial Direct Current Stimulation Before Occipital Nerve Stimulation in Fibromyalgia. Clin J Pain 2018;34:421–7. [DOI] [PubMed] [Google Scholar]
  • 67.To WT, James E, Ost J, Hart J, Jr, De Ridder D, Vanneste S. Differential effects of bifrontal and occipital nerve stimulation on pain and fatigue using transcranial direct current stimulation in fibromyalgia patients. J Neural Transm (Vienna) 2017;124:799–808. [DOI] [PubMed] [Google Scholar]
  • 68.Ridder D, Vanneste S. Occipital Nerve Field Transcranial Direct Current Stimulation Normalizes Imbalance Between Pain Detecting and Pain Inhibitory Pathways in Fibromyalgia. Neurotherapeutics 2017;14:484–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Plazier M, Ost J, Stassijns G, De Ridder D, Vanneste S. C2 Nerve Field Stimulation for the Treatment of Fibromyalgia: A Prospective, Double-blind, Randomized, Controlled Cross-over Study. Brain Stimul 2015;8:751–7. [DOI] [PubMed] [Google Scholar]
  • 70.Plazier M, Ost J, Snijders E, Gilbers M, Vancamp T, De Ridder D, et al. Laser-Evoked Potentials in Fibromyalgia: The Influence of Greater Occipital Nerve Stimulation on Cerebral Pain Processing. Neuromodulation 2015;18:376–83. [DOI] [PubMed] [Google Scholar]
  • 71.Germano Maciel D, Trajano da Silva M, Rodrigues JA, Viana Neto JB, de França IM, Melo ABM, et al. Low-level laser therapy combined to functional exercise on treatment of fibromyalgia: a double-blind randomized clinical trial. Lasers Med Sci 2018;33:1949–59. [DOI] [PubMed] [Google Scholar]
  • 72.da Silva MM, Albertini R, de Tarso Camillo de Carvalho P, Leal-Junior ECP, Bussadori SK, Vieira SS, et al. Randomized, blinded, controlled trial on effectiveness of photobiomodulation therapy and exercise training in the fibromyalgia treatment. Lasers Med Sci 2018;33:343–51. [DOI] [PubMed] [Google Scholar]
  • 73.Vayvay ES, Tok D, Turgut E, Tunay VB. The effect of Laser and taping on pain, functional status and quality of life in patients with fibromyalgia syndrome: A placebo- randomized controlled clinical trial. J Back Musculoskelet Rehabil 2016;29:77–83. [DOI] [PubMed] [Google Scholar]
  • 74.Nakajima F, Komoda A, Aratani S, Fujita H, Kawate M, Nakatani K, et al. Effects of xenon irradiation of the stellate ganglion region on fibromyalgia. J Phys Ther Sci 2015;27:209–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Ruaro JA, Fréz AR, Ruaro MB, Nicolau RA. Low-level laser therapy to treat fibromyalgia. Lasers Med Sci 2014;29:1815–9. [DOI] [PubMed] [Google Scholar]
  • 76.Panton L, Simonavice E, Williams K, Mojock C, Kim JS, Kingsley JD, et al. Effects of Class IV laser therapy on fibromyalgia impact and function in women with fibromyalgia. J Altern Complement Med 2013;19:445–52. [DOI] [PubMed] [Google Scholar]
  • 77.de Souza RC, de Sousa ET, Scudine KG, Meira UM, de Oliveira E Silva EM, et al. Low-level laser therapy and anesthetic infiltration for orofacial pain in patients with fibromyalgia: a randomized clinical trial. Med Oral Patol Oral Cir Bucal 2018;23:e65–e71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Molina-Torres G, Rodríguez-Archilla A, Matarán-Peñarrocha G, Albornoz-Cabello M, Aguilar-Ferrándiz ME, Castro-Sánchez AM. Laser Therapy and Occlusal Stabilization Splint for Temporomandibular Disorders in Patients With Fibromyalgia Syndrome: A Randomized, Clinical Trial. Altern Ther Health Med 2016;22:23–31. [PubMed] [Google Scholar]
  • 79.Dos Santos RC, Souza Guedes KWHS, de Sousa Pinto JM, Oliveira MF. Acute low-level laser therapy effects on peripheral muscle strength and resistance in patients with fibromyalgia. Lasers Med Sci 2020;35:505–10. [DOI] [PubMed] [Google Scholar]
  • 80.Moretti FA, Marcondes FB, Provenza JR, Fukuda TY, de Vasconcelos RA, Roizenblatt S. Combined therapy (ultrasound and interferential current) in patients with fibromyalgia: once or twice in a week? Physiother Res Int 2012;17:142–9. [DOI] [PubMed] [Google Scholar]
  • 81.Yilmaz N, Kiyak E. The effects of local cold application on fibromyalgia pain. Int J Rheum Dis 2017;20:929–34. [DOI] [PubMed] [Google Scholar]
  • 82.Rivera J, Tercero MJ, Salas JS, Gimeno JH, Alejo JS. The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin. Rheumatol Int 2018;38:2243–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Vitenet M, Tubez F, Marreiro A, Polidori G, Taiar R, Legrand F, et al. Effect of whole body cryotherapy interventions on health-related quality of life in fibromyalgia patients: A randomized controlled trial. Complement Ther Med 2018;36:6–8. [DOI] [PubMed] [Google Scholar]
  • 84.Coskun Benlidayi I. Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatol Int 2019;39:781–91. [DOI] [PubMed] [Google Scholar]
  • 85.Klemm P, Becker J, Aykara I, Asendorf T, Dischereit G, Neumann E, et al. Serial whole-body cryotherapy in fibromyalgia is effective and alters cytokine profiles. Adv Rheumatol 2021;61:3. [DOI] [PubMed] [Google Scholar]
  • 86.Ramon S, Gleitz M, Hernandez L, Romero LD. Update on the efficacy of extracorporeal shockwave treatment for myofascial pain syndrome and fibromyalgia. Int J Surg 2015;24(Pt B):201–6. [DOI] [PubMed] [Google Scholar]
  • 87.Poitras S, Brosseau L. Electrotherapeutic Modalities and Physical Agents, Editors: Dagenais S, Haldeman S. Evidence-Based Management of Low Back Pain, Mosby; 2012, Pages 188–204, ISBN 9780323072939. 10.1016/B978-0-323-07293-9.00014-3. [DOI] [Google Scholar]
  • 88.Grabois M, Benny B, Chan KT. In: Physical Medicine Techniques in Pain Management, Editors: Benzon HT, Rathmell JP, Wu CL, Turk DC, Argoff CE. Raj’s Practical Management of Pain (Fourth Edition), Mosby; 2008, Pages 757–771, ISBN 9780323041843, 10.1016/B978-032304184-3.50043-1. [DOI] [Google Scholar]

Articles from Mediterranean Journal of Rheumatology are provided here courtesy of Greek Rheumatology Society and Professional Association of Rheumatologists

RESOURCES